Takamasa Kanbe

1.1k citations
17 papers · 845 indexed · h-index 11

Takamasa Kanbe

16 papers receiving 833 citations

Peers

Takamasa Kanbe
Comparison fields: 5 of 79
  • Hepatology 77
  • Cancer Research 121
  • Biochemistry 43
  • Molecular Biology 484
  • Physiology 146
Replace N Sawada with:
N Sawada Japan
Salvador Naranjo‐Suarez Spain
Annemieke IJpenberg Switzerland
Michi Tanaka Japan
Howard E. Boudreau United States
Sumio Kawata Japan
Kensuke Kojima Japan
Ming Zeng China
Chul-Koo Cho South Korea
Takamasa Kanbe relative to N Sawada Japan N Sawada's profile →
Citations per field
00.5×2.7×
N Sawada · 1×
Citations per year

Countries citing papers authored by Takamasa Kanbe

Since Specialization
Citations

This map shows the geographic impact of Takamasa Kanbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takamasa Kanbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takamasa Kanbe more than expected).

Fields of papers citing papers by Takamasa Kanbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takamasa Kanbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takamasa Kanbe. The network helps show where Takamasa Kanbe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takamasa Kanbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takamasa Kanbe Line = papers co-authored together Takamasa Kanbe links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20230
2 201318
3 201031
4
[Effectiveness of S-1 therapy for unresectable/advanced pancreas cancer].
20091
5 2007113
6 20078
7
Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients.
200711
8
Regulation of hepatic oval cell proliferation by adenoviral mediated hepatocyte growth factor gene transfer and signal transduction inhibitors.
20077
9 200611
10 20062
11 200515
12 200514
13 20056
14 200563
15 2004120
16 200352
17 2001373

About Takamasa Kanbe

Takamasa Kanbe is a scholar working on Hepatology, Cancer Research and Clinical Biochemistry, having authored 17 papers that have together received 845 indexed citations. Recurring topics across this work include Liver physiology and pathology (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers), DNA Repair Mechanisms (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Pancreatic function and diabetes (2 papers), Selenium in Biological Systems (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Hepatology (77 citations), Cancer Research (121 citations) and Biochemistry (43 citations). Takamasa Kanbe has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Hiroshi Fukuhara, Minoru Isomura, Masataka Onizuka, Hara P. Ghosh, Tadaichi Kitamura, Tomoko Maruyama, Mathew T. Pletcher, Masami Kuramochi, Yoshinori Murakami and Takahiro Nobukuni.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026